2022 Fertility Patient Survey
A Peek Behind the Curtain:
Patients' Knowledge, Fears, and Transparency into an Embryo's Journey
Summary Findings
Background
RESOLVE: The National Infertility Association partnered with Untold Research, an independent research firm, to conduct an online survey designed to understand the experiences, knowledge, and opinions of those exploring, considering, undergoing, or who have undergone fertility treatments.
Between September 16 and October 2, 2022, 637 adults completed an online survey. RESOLVE invited patients to participate through email, social media posts and other outreach efforts.
Summary Findings
When Selecting a Fertility Clinic...
91% of patients indicated that the most important factor is accurate egg/embryo transfer describing this as “very important.”
82% of patients rank safe egg/embryo storage as “very important” – more than clinic success rates, relationship with their doctor, cost, location and recommendations from doctors or friends.
TOP 3 PATIENT FEARS
in specimen freezing/storage processes are:
A Lack of Knowledge of Embryo & Egg Storage
17% of patient consider themselves as very knowledgeable about egg/embryo storage
88% of patients don't know how often wellness checks are performed on their frozen specimens' environment
61% of patients believe that mixups will be avoided due to sheer trust in their doctor and clinic
94% of patients said they want automation as part of their storage process that includes:
digital labels, touch-of-a-button reports, multiple daily checks, and alarms.
2% of patients want an exclusively manual process.
Patients Want Automated Storage
Transparency & Peace of Mind
More than 90% of patients want full transparency around each of the following:
- Specimen labeling
- Traceability of specimens
- Specimen monitoring processes and standards
- Protocols and procedures for storage
- Specimen storage conditions
78% of patients believe transparency will give them greater peace of mind.
The Details
Between September 16 and October 2, 2022, 637 adults completed an online survey. RESOLVE invited patients to participate through email, social media posts and other outreach efforts.
Respondents were predominantly women ages 28-47 in the United States.
Throughout this report, survey respondents are referred to as “patients,” regardless of where they are in their fertility
journey. These individuals either have previously or are currently exploring and/or considering treatment options,
selecting and/or working with a fertility doctor/clinic, actively undergoing fertility treatments, and have completed or are
taking a break from fertility treatments.
TMRW Life Sciences provided an unrestricted educational grant to fund the survey.